Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors

Bone Marrow Transplant. 2017 Jan;52(1):132-134. doi: 10.1038/bmt.2016.189. Epub 2016 Jul 18.

Authors

Z DeFilipp¹, C B Rosand¹, D A Goldstein¹, V A Master², B C Carthon¹, W B Harris¹, O Kucuk¹, Z Al-Kadhimi¹, J B Cohen¹, C R Flowers¹, M J Lechowicz¹, A K Nooka¹, J L Kaufman¹, A A Langston¹, Z Chen³, J Arora³, E K Waller¹

Affiliations

¹ Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
² Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
³ Department of Biostatistics and Bioinformatics, Emory University School of Public Health, Atlanta, GA, USA.

PMID: 27427922
DOI: 10.1038/bmt.2016.189

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Male
Middle Aged
Neoplasms, Germ Cell and Embryonal / drug therapy*
Neoplasms, Germ Cell and Embryonal / pathology
Neoplasms, Germ Cell and Embryonal / therapy*
Transplantation, Autologous / methods*
Young Adult